IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 17 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $60,000 | -18.9% | 285,154 | 0.0% | 0.00% | – |
| Q2 2018 | $74,000 | +270.0% | 285,154 | +258.4% | 0.00% | – |
| Q1 2018 | $20,000 | -13.0% | 79,566 | +26.8% | 0.00% | – |
| Q3 2017 | $23,000 | -58.2% | 62,760 | -1.0% | 0.00% | – |
| Q2 2017 | $55,000 | -68.9% | 63,377 | +13.8% | 0.00% | – |
| Q1 2017 | $177,000 | +41.6% | 55,677 | -8.3% | 0.00% | – |
| Q4 2016 | $125,000 | – | 60,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEDBUSH SECURITIES INC | 276,530 | $5,000 | 0.00% |
| IFP Advisors, Inc | 95 | $0 | 0.00% |
| Certified Advisory Corp | 20 | $0 | 0.00% |